Analysis of changes in circular RNA expression and construction of ceRNA networks in human dilated cardiomyopathy

Zhenhao Lin, Yongchao Zhao, Fangjie Dai, Enyong Su, Fuhai Li, Yan YanJournal of Cellular and Molecular Medicine 2021 · DOI

TL;DR

This study investigates the role of circular RNAs (circRNAs) in dilated cardiomyopathy (DCM), a severe heart condition. By analyzing RNA sequencing data from DCM patients and healthy controls, researchers identified altered circRNA expression and constructed complex regulatory networks, suggesting circRNAs could be potential therapeutic targets.

What Problem Does This Paper Address?

Dilated cardiomyopathy (DCM) is a serious heart disease characterized by enlarged ventricles and weakened pumping function, leading to heart failure and increased mortality. Despite its prevalence, the precise molecular mechanisms underlying DCM remain unclear, hindering the development of effective treatments. While non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), have been implicated in cardiovascular diseases, the specific role of circular RNAs (circRNAs) in human DCM has not been thoroughly explored. CircRNAs are a class of RNA molecules with a unique circular structure that makes them highly stable and capable of acting as "sponges" for miRNAs, thereby influencing gene expression. This paper aims to elucidate the changes in circRNA expression in DCM and to understand their regulatory roles by constructing competitive endogenous RNA (ceRNA) networks.

Methods

The researchers employed a multi-faceted approach:

  • RNA Sequencing (RNA-Seq): This high-throughput technique was used to comprehensively profile both circRNAs and messenger RNAs (mRNAs) in heart tissue samples from DCM patients and healthy controls.
  • Quantitative Real-Time PCR (qRT-PCR): This method was used to validate the expression levels of selected differentially expressed circRNAs and mRNAs identified by RNA-Seq, ensuring the reliability of the sequencing data.
  • Bioinformatic Analysis:
    • CircRNA and mRNA Identification: Specialized software (STAR, DCC, hisat2) was used to map and identify circRNAs and mRNAs from the sequencing data.
  • Differential Expression Analysis: EdgeR and Cuffdiff software were utilized to identify circRNAs and mRNAs that showed significant changes in expression between the DCM and control groups.
  • ceRNA Network Construction: Proprietary software and the miRanda and TargetScan databases were used to predict miRNA targets and construct circRNA-miRNA-mRNA networks based on the ceRNA theory. This involved identifying circRNAs and mRNAs that share common miRNA binding sites and exhibit coordinated expression changes.
  • Functional Enrichment Analysis: Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed on the target mRNAs to understand the potential biological functions associated with the dysregulated circRNAs.

Datasets

The study utilized heart tissue samples from:

  • DCM Patients: Left ventricular wall samples from patients diagnosed with DCM.
  • Healthy Controls: Heart samples from healthy donors (accident victims).

No new benchmarks were introduced; the study focused on analyzing existing data types (circRNA and mRNA expression) in the context of a specific disease.

Key Insights and Ideas

  • CircRNAs are Dysregulated in DCM: The study provides strong evidence that circRNA expression patterns are significantly altered in the hearts of individuals with DCM compared to healthy controls. This suggests a potential role for these molecules in the disease's pathogenesis.
  • Complex Regulatory Networks: The construction of circRNA-miRNA-mRNA networks reveals intricate regulatory interactions. This highlights that circRNAs don't act in isolation but are part of a sophisticated molecular ecosystem influencing gene expression.
  • Potential Therapeutic Targets: By identifying specific circRNAs and their associated networks, the research points towards these molecules as potential candidates for diagnostic biomarkers or therapeutic interventions for DCM.
  • Functional Implications: GO and KEGG analyses link the dysregulated circRNAs to crucial cellular processes and pathways involved in cardiac function, such as cellular macromolecule metabolism, protein modification, and signaling pathways like Ras and MAPK.

Key Results

  • CircRNA Identification: A total of 9585 circRNAs were detected in the control and DCM groups.
  • Differential CircRNA Expression: 298 circRNAs were found to be differentially expressed, with 213 up-regulated and 85 down-regulated in DCM patients.
  • mRNA Identification: A total of 22050 mRNAs were detected.
  • Differential mRNA Expression: 1742 mRNAs were differentially expressed, with 617 up-regulated and 1125 down-regulated in DCM patients.
  • ceRNA Network Construction: Two ceRNA networks were constructed: one involving top 10 down-regulated circRNAs (with 6 miRNAs and 66 mRNAs) and another with top 10 up-regulated circRNAs (with 13 miRNAs and 54 mRNAs).
  • Functional Enrichment: Up-regulated mRNAs were enriched in terms related to cellular macromolecule metabolic processes and protein modification, while down-regulated mRNAs were associated with regulation of multicellular organismal processes and signal transduction. KEGG analysis highlighted pathways like Ras signaling and MAPK signaling.

Limitations and Future Work

  • Human Tissue Focus: While the study uses human heart samples, the findings would benefit from validation in larger cohorts and potentially in animal models to further elucidate causal relationships.
  • In Vitro/In Vivo Validation: The study primarily relies on bioinformatic predictions and qRT-PCR validation of expression. Future work could involve experimental validation of the predicted circRNA-miRNA-mRNA interactions using techniques like luciferase assays or knockdown/overexpression studies.
  • Causality: The study identifies associations between circRNA expression and DCM. Establishing a direct causal link between specific circRNAs and the development or progression of DCM would be a crucial next step.
  • Therapeutic Potential: Further research is needed to explore the therapeutic potential of targeting these circRNAs for DCM treatment. This could involve developing specific inhibitors or activators of these molecules.

Summary updated

Abstract

Dilated cardiomyopathy (DCM) is a severe life-threatening disease worldwide, and the underlying mechanisms remain unclear. Circular RNAs (circRNAs) have been reported to play important roles in various cardiovascular diseases and can function as competitive endogenous RNAs (ceRNAs). However, their role in human DCM has not been fully elucidated. In the present study, heart samples from DCM patients and healthy controls were used to identify circRNAs by RNA sequencing. Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was conducted to validate differentially expressed circRNAs and mRNAs. A total of 9585 circRNAs and 22050 mRNAs were detected in the two groups. Overall, 213 circRNAs and 617 mRNAs were significantly up-regulated in the DCM group compared with the control group. Similarly, 85 circRNAs and 1125 mRNAs were significantly down-regulated. According to the ceRNA theory, circRNAs can indirectly interact with mRNAs by directly binding to microRNAs (miRNAs), and circRNAs and mRNAs should be concurrently either up-regulated or down-regulated. Based on this theory, we constructed two circRNA-miRNA-mRNA networks by using the RNA sequencing data and prediction by proprietary software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to probe the potential functions of differentially expressed circRNAs. In conclusion, this study revealed that the expression of cardiac circRNAs was altered in human DCM and explored the potential functions of circRNAs by constructing ceRNA networks. These findings provide a foundation for future studies of circRNAs in DCM.
BibTeX
@article{lin2021analysis,
  author = {Zhenhao Lin and Yongchao Zhao and Fangjie Dai and Enyong Su and Fuhai Li and Yan Yan},
  title = {{Analysis of changes in circular RNA expression and construction of ceRNA networks in human dilated cardiomyopathy}},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2021},
  doi = {10.1111/jcmm.16251},
}
Figure